Cargando…
Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release
BACKGROUND: A formulation of crush-resistant extended-release opioids may deter abuse. The purpose of this study was to evaluate the bioequivalence of oxymorphone extended-release (Oxy-ER) and a crush-resistant formulation of oxymorphone extended-release (Oxy-CRF). METHODS: In three open-label, rand...
Autores principales: | Benedek, Irma H, Jobes, Janet, Xiang, Qinfang, Fiske, William D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232172/ https://www.ncbi.nlm.nih.gov/pubmed/22162639 http://dx.doi.org/10.2147/DDDT.S24372 |
Ejemplares similares
-
Review of oral oxymorphone in the management of pain
por: Sloan, Paul
Publicado: (2008) -
Concomitant Filled Prescriptions of Oxymorphone or Oxycodone with CYP3A Inhibitors and Inducers
por: Coyle, D. Tyler, et al.
Publicado: (2020) -
A Comparison of Daily Average Consumption (DACON) of Oxycodone and Oxymorphone Long-Acting Oral Tablets
por: Rubino, Mark, et al.
Publicado: (2011) -
Efficacy of systemic HS-198, an analogue of oxymorphone, on cancer pain-related behaviour in mice
por: Asim, Muhammad F, et al.
Publicado: (2011) -
Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone — Indiana, 2015
por: Conrad, Caitlin, et al.
Publicado: (2015)